Kovai Medical Center & Hospital Ltd

Kovai Medical Center & Hospital Ltd

₹ 4,118 -0.17%
19 Apr - close price
About

Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]

Key Points

Hospital Portfolio
The company operates peripheral centers in Coimbatore, Sulur, Coimbatore (city center), Erode, and Kovilpalayam, along with hospitals having a combined capacity of approximately 2250 beds. [1]

  • Market Cap 4,506 Cr.
  • Current Price 4,118
  • High / Low 4,235 / 1,903
  • Stock P/E 28.5
  • Book Value 714
  • Dividend Yield 0.12 %
  • ROCE 16.8 %
  • ROE 17.7 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • The company has delivered a poor sales growth of 11.6% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
179 199 239 218 229 220 236 252 264 267 275 303 321
127 141 164 154 165 166 174 184 193 200 206 217 225
Operating Profit 52 58 75 64 64 54 62 68 71 67 68 85 96
OPM % 29% 29% 31% 29% 28% 25% 26% 27% 27% 25% 25% 28% 30%
2 5 2 2 4 3 4 3 4 5 6 4 5
Interest 8 9 11 11 11 10 10 10 10 10 10 8 7
Depreciation 17 18 19 23 22 21 23 22 22 22 22 23 23
Profit before tax 29 36 47 32 36 26 32 39 43 41 42 58 71
Tax % 30% 26% 25% 25% 27% 28% 27% 23% 27% 25% 26% 26% 25%
21 27 35 24 26 19 24 30 31 31 31 43 53
EPS in Rs 18.96 24.55 32.19 22.07 23.82 17.20 21.74 27.67 28.46 27.93 28.38 39.67 48.53
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
222 297 334 402 465 531 588 628 712 690 905 1,020 1,165
179 227 261 307 374 406 459 494 540 495 645 746 848
Operating Profit 43 70 73 94 92 125 129 135 171 195 261 274 317
OPM % 20% 24% 22% 23% 20% 23% 22% 21% 24% 28% 29% 27% 27%
2 3 5 7 8 6 7 8 10 12 12 14 21
Interest 17 27 24 20 17 15 13 15 18 33 46 43 36
Depreciation 12 15 16 21 21 24 34 36 52 68 85 89 90
Profit before tax 16 31 37 59 62 92 89 93 112 106 141 155 211
Tax % 26% 32% 36% 35% 35% 35% 35% 35% 15% 27% 26% 25%
12 21 24 39 40 60 58 60 95 78 104 116 158
EPS in Rs 10.92 19.42 21.68 35.37 36.95 54.81 52.99 54.96 86.44 71.00 95.28 105.80 144.51
Dividend Payout % 11% 8% 7% 4% 7% 5% 6% 5% 3% 4% 6% 9%
Compounded Sales Growth
10 Years: 13%
5 Years: 12%
3 Years: 13%
TTM: 20%
Compounded Profit Growth
10 Years: 19%
5 Years: 15%
3 Years: 7%
TTM: 52%
Stock Price CAGR
10 Years: 38%
5 Years: 40%
3 Years: 51%
1 Year: 107%
Return on Equity
10 Years: 21%
5 Years: 19%
3 Years: 18%
Last Year: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 11 11 11 11 11 11 11 11 11 11 11 11 11
Reserves 50 70 91 127 165 224 276 332 420 499 598 708 770
228 209 184 163 158 125 202 378 543 623 550 511 392
50 55 65 85 96 103 116 129 134 148 184 213 228
Total Liabilities 339 345 351 386 430 464 605 850 1,108 1,281 1,343 1,443 1,401
288 279 277 281 337 354 443 469 643 1,033 1,085 1,088 1,073
CWIP 0 5 5 17 10 6 13 227 300 45 5 23 39
Investments 4 4 4 4 4 4 0 0 0 0 0 0 0
46 57 65 85 78 100 149 153 165 203 253 331 288
Total Assets 339 345 351 386 430 464 605 850 1,108 1,281 1,343 1,443 1,401

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
56 62 68 97 85 99 87 126 152 186 262 263
-77 -9 -12 -80 -113 -83 -192 -352 -335 -180 -292 -358
17 -48 -52 -43 -24 -50 60 160 113 38 -119 -86
Net Cash Flow -4 6 4 -26 -53 -33 -45 -66 -70 44 -149 -180

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 5 5 8 9 7 8 8 6 4 7 8 9
Inventory Days 36 35 33 25 22 20 23 20 23 19 19 18
Days Payable 32 29 35 53 47 37 43 47 46 29 20 35
Cash Conversion Cycle 9 11 6 -19 -19 -9 -12 -21 -19 -2 6 -8
Working Capital Days -60 -49 -43 -56 -52 -47 -48 -49 -36 -38 -38 -38
ROCE % 12% 20% 21% 27% 25% 31% 24% 18% 15% 13% 16% 17%

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
55.76% 55.74% 55.74% 55.71% 55.76% 55.76% 55.76% 55.98% 56.26% 56.43% 56.44% 56.47%
2.08% 2.08% 2.09% 2.13% 2.12% 2.14% 2.15% 2.18% 2.20% 2.25% 2.24% 0.34%
1.43% 1.72% 1.77% 1.95% 1.95% 1.92% 1.97% 2.07% 2.19% 2.09% 2.09% 4.18%
40.73% 40.46% 40.40% 40.21% 40.17% 40.19% 40.12% 39.79% 39.34% 39.24% 39.24% 39.02%
No. of Shareholders 10,0769,9519,5179,6889,5599,5449,4649,67410,48710,73010,33811,918

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents